Cervical cancer prevention in East Africa
Project 1: A Public Health Approach to Cervical Cancer Prevention in East Africa
This project tries public-health approaches to prevent cervical cancer for people living in East Africa.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11416620 on NIH RePORTER |
What this research studies
If you lived in a participating community, the team would work with local clinics and health workers to increase access to prevention like HPV vaccination and regular cervical screening. They would use community outreach, education, and training so more people know about and can get follow-up care when needed. The project partners with East African health systems to adapt these strategies to local needs and collect data on what works best. Researchers will track outcomes to learn which approaches most reduce precancer and cancer over time.
Who could benefit from this research
Good fit: Ideal participants are people with a cervix living in the East African communities served who are eligible for HPV vaccination or cervical screening.
Not a fit: People outside the project area or those who already have advanced cervical cancer are unlikely to receive direct benefit from a prevention-focused program.
Why it matters
Potential benefit: If successful, this work could reduce cervical cancer cases and deaths by improving vaccination, screening, and timely follow-up.
How similar studies have performed: HPV vaccination and organized screening programs have lowered cervical cancer rates where implemented, though adapting and scaling these interventions in East Africa is still an active area of work.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.